Cardiovascular risk calculators: understanding differences and realising economic implications

Silvana Quaglini1, Mario Stefanelli, Lorenzo Boiocchi

  • 1Department of Computer Science and Systems, University of Pavia, via Ferrata 1, 27100 Pavia, Italy. sil@aim.unipv.it

Insights

Global cardiovascular risk assessment tools vary significantly, impacting primary prevention strategies and medication decisions for hypercholesterolemia. Different risk calculators yield diverse results, affecting patient care and healthcare costs.

Area of Science:

  • Cardiology
  • Public Health
  • Health Economics

Background:

  • Global cardiovascular risk assessment is crucial for primary prevention of cardiovascular diseases.
  • Risk stratification for individuals without prior cardiovascular history is complex, influencing intervention intensity.
  • Guidelines for general practitioners on pharmaceutical prescriptions based on risk classes exist in several countries.

Purpose of the Study:

  • To investigate the variability of cardiovascular risk calculators.
  • To assess the impact of different risk calculators on Statin prescription eligibility in Italy.
  • To estimate the economic implications of using various risk assessment tools.

Main Methods:

  • A comprehensive review of online and literature-based cardiovascular risk calculators.
  • A simulation study using diverse risk calculators for the same individual profiles.
  • Economic impact analysis based on simulation results.

Main Results:

  • A wide array of cardiovascular risk calculators were identified.
  • Significant discrepancies in risk scores were observed when applying different calculators to the same individuals.
  • The choice of calculator can influence Statin eligibility and associated healthcare costs.

Conclusions:

  • The heterogeneity of cardiovascular risk calculators poses challenges for consistent primary prevention.
  • Standardization or clear guidance on calculator selection is needed for accurate risk assessment.
  • Variability in risk calculation has potential economic consequences for healthcare systems.

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...